SH
TEVA icon

SeaTown Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

SeaTown Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-579,022
Closed -$9.08M – 75
2019
Q1 		$9.08M Buy
+579,022
New +$10.2M 1.07% 39
2017
Q1 		– Sell
-231,500
Closed -$8.39M – 52
2016
Q4 		$8.39M Buy
+231,500
New +$9.24M 1.93% 20
2014
Q1 		– Sell
-384,016
Closed -$15.4M – 22
2013
Q4 		$15.4M Buy
384,016
+259,016
+207% +$10.2M 5.6% 7
2013
Q3 		$4.78M Buy
+125,000
New +$4.88M 1.81% 11

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SeaTown Holdings's TEVA Position: Q2 2019 in Review

SeaTown Holdings sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 579,022 shares — an estimated $9.08M sold.

SeaTown Holdings first reported a position in TEVA in Q3 2013 and held it in 4 quarters. The position peaked at $15.4M in Q4 2013. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • SeaTown Holdings reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • SeaTown Holdings sold 579,022 Teva Pharmaceuticals shares in Q2 2019, an estimated $9.08M.
  • SeaTown Holdings first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • SeaTown Holdings's Teva Pharmaceuticals position peaked at $15.4M in Q4 2013.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on SeaTown Holdings's 13F filing for Q2 2019, filed 1 Aug 2019.